MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation

    C. Benedict, D. Fredericks, C. Manganiello, H. Herrstrom, D. Schmitt, K. Lyons (Topeka, KS, USA)

    Objective: To demonstrate the effects of an interdisciplinary team approach in the evaluation and treatment of Parkinson’s disease (PD) patients, during inpatient rehabilitation. Background:  PD…
  • 2017 International Congress

    Preventing Levodopa Induced Dyskinesia with Docosohexanoid Acid in Parkinson Disease

    K. Chung, B. Lobb (Portland, OR, USA)

    Objective: The purpose of this study was to determine if Docosohexanoic acid (DHA) affects the speed and severity of development of levodopa induced dyskinesia (LID) in subjects starting levodopa (LD).…
  • 2017 International Congress

    A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD

    H.-L. Chiang, F. Chang, D. Tsui, Y. Tai, A. Ha, N. Mahant, J. Griffith, D. Galea, S. Kim, B. Cruse, H. Morales-Briceño (New Taipei City, Taiwan)

    Objective: To compare the clinical, functional and quality of life (QoL) outcomes in patients with advanced Parkinson’s disease (PD) following treatment with apomorphine (APO), either…
  • 2017 International Congress

    Postural Instability is a Predictor for Driving Cessation Among Parkinson’s Disease Drivers: A Study of a Computer-Based 3D Driving Simulator.

    O. Jitkritsadakul, S. Krootjohn, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To develop tests to predict the driving capability of PD patients. Background: Continuing driving competence is a concern for Parkinson’s disease (PD) patients and…
  • 2017 International Congress

    [18F]-AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP

    S. Coakeley, S.S. Cho, Y. Koshimori, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: This study was designed to investigate the binding of [18F]-AV-1451 to neuromelanin in parkinsonisms. Uptake in the substantia nigra of Parkinson’s disease (PD) and…
  • 2017 International Congress

    Altered intrinsic brain functional connectivity in drug-naïve Parkinson’s disease with LRRK2 mutation

    Y. Hou, C. Luo, J. Yang, R. Ou, W. Song, Y. Chen, Q. Gong, H. Shang (Chengdu, China)

    Objective: This study aimed to compare the alterations in the cortico-striatal functional connectivity (FC) of drug-naïve Parkinson’s disease (PD) patients with the leucine-rich repeat kinase…
  • 2017 International Congress

    Altered Resting-State Functional Interhemispheric Connectivity in Parkinson’s Disease

    X. Dan, S. Lin, A. Liu, J. Wang, T. Wu, P. Chan, M. McKeown (Beijing, China)

    Objective: To examine direct interhemispheric functional connectivity (FCi) in Parkinson's disease (PD) during resting-state fMRI and to investigate the relations between observed connectivity changes and…
  • 2017 International Congress

    The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report

    A. Tran, M. Amin, R. Burns (Phoenix, AZ, USA)

    Objective: The role of MRI and DAT scan in Vascular Parkinsonism: A Case Report Background: DaTscan has become a widely used clinical tool to help clinicians…
  • 2017 International Congress

    Experience and outcomes of the first Movement Disorders Clinic in Honduras.

    J. Ortiz, A. Medina, F. Naranjo (Tegucigalpa, Honduras)

    Objective: To describe the frequency and clinical characteristics using standardized scales in patients with movement disorders (MD) recruited by a referral system in Tegucigalpa, Honduras.…
  • 2017 International Congress

    A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease

    A. Sauerbier, L. Klingelhoefer, R. Banerjee, S. Diaconu, R. Erro, T. Farombi, S. Gangadharan, A. Macerollo, L. Chahine, O. Jitkritsadakul, R. Biundo, M. Grilo, H. Dafsari, G. Pagano, F. Niccolini, N. Titova (London, United Kingdom)

    Objective: To collect details of linguistic validations and translations of the non-motor symptoms questionnaire (NMSQuest) and non-motor symptoms scale (NMSScale) globally.  Background: The patient completed…
  • « Previous Page
  • 1
  • …
  • 326
  • 327
  • 328
  • 329
  • 330
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley